Plerixafor and resatorvid inhibit hepatitis B virus in vitro by upregulating elongation factor Tu GTP-binding domain containing 2

BACKGROUND: An increase in the demand for a functional cure has accelerated research on new methods of therapy for chronic hepatitis B, which is mainly focused on restoring antiviral immunity for controlling viral infections. Previously, we had described elongation factor Tu GTP-binding domain conta...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jinyuan, Li, Yuwen, Hu, Pingping, Xu, Ruirui, Yuan, Hui, Zhang, Wen, Feng, Tiantong, Liu, Rui, Li, Wenting, Zhu, Chuanlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986551/
https://www.ncbi.nlm.nih.gov/pubmed/36891156
http://dx.doi.org/10.3389/fcimb.2023.1118801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986551/
https://www.ncbi.nlm.nih.gov/pubmed/36891156
http://dx.doi.org/10.3389/fcimb.2023.1118801

Ejemplares similares